The Cannabis abuse screening test (CAST) is a short test used for screening those with problematic cannabis use. Recently, its invariance toward age was tested in an Israeli sample of cannabis users, but this study had some sample and methodological limitations: it was conducted in a volunteer sample aged 18–40 and considered the CAST items as continuous variables, although they are based on 5-point Likert scales. We thus tested the CAST invariance toward age (15–24, 25–34, and 35–64 years old) using a French probabilistic sample of 1,351 past-year cannabis users aged 15–64 and using appropriate methods for categorical items and survey weights. Factors retained (non-recreational use and problems) were the same as those mentioned in previous studies. Scalar invariance held for the “problems” factor but only partial scalar invariance was supported for the “non-recreational use” factor. Caution is thus needed when the CAST score is compared across age groups.

Keywords:
Cannabis abuse screening test . Age invariance . Confirmatory factor analysis
1.
Annaheim B, Legleye S: Screening for Cannabis-Related Problems: Biology, Diagnosis, Treatment and Pharmacology; in Preedy VR (ed): Handbook of Cannabis Related Pathology Biology, Pharmocology, Diagnosis and Treatment. London, Elsevier, 2017.
2.
Legleye S, Karila L, Beck F, Reynaud M: Validation of the CAST, a general population Cannabis abuse screening test. J Subst Use 2007; 12: 233–242.
3.
Legleye S, Piontek D, Kraus L: Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents. Drug Alcohol Depend 2011; 113: 229–235.
4.
Legleye S, Piontek D, Kraus L, Morand E, Falissard B: A validation of the Cannabis Abuse Screening Test (CAST) using a latent class analysis of the DSM-IV among adolescents. Int J Methods Psychiatr Res 2013; 22: 16–26.
5.
Cuenca-Royo AM, Sánchez-Niubó A, Forero CG, Torrens M, Suelves JM, Domingo-Salvany A: Psychometric properties of the CAST and SDS scales in young adult cannabis users. Addict Behav 2012; 37: 709–715.
6.
Gyepesi A, Urban R, Farkas J, Kraus L, Piontek D, Paksi B, Horvath G, Magi A, Eisinger A, Pilling J, Kokonyei G, Kun B, Demetrovics Z: Psychometric properties of the Cannabis Abuse Screening Test in Hungarian samples of adolescents and young adults. Eur Addict Res 2014; 20: 119–128.
7.
Bastiani L, Siciliano V, Curzio O, Luppi C, Gori M, Grassi M, Molinaro S: Optimal scaling of the CAST and of SDS Scale in a national sample of adolescents. Addict Behav 2013; 38: 2060–2067.
8.
Legleye S, Guignard R, Richard JB, Ludwig K, Pabst A, Beck F: Properties of the Cannabis Abuse Screening Test (CAST) in the general population. Int J Methods Psychiatr Res 2015; 24: 170–183.
9.
Legleye S: The Cannabis abuse screening test and the DSM-5 in the general population: optimal thresholds and underlying common structure using multiple factor analysis. Int J Methods in Psychatr Res 2017, Epub ahead of print.
10.
Sznitman SR: The Cannabis Abuse Screening Test (CAST) revisited: examining measurement invariance by age. Int J Methods Psychatr Res 2016; 26.
11.
Muthen LK, Muthen BO: Mplus User’s Guide. Los Angeles, 2010.
12.
Richard JB, Gautier A, Guignard R, Léon C, Beck F: Méthode d’enquête du Baromètre santé 2014: Baromètre Santé. Saint-Denis, INPES, 2014, p 20.
13.
Brown TA: Confirmatory Factor Analysis for Applied Research, ed 2d. New York, The Guilford Press, 2015.
14.
Kline RB: Principles and Practice of Structural Equation Modeling, ed 4th. New York, The Guilford Press, 2015.
15.
Hu L, Bentler PM: Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling 1999; 6: 1–55.
16.
Asparouhov T: Sampling weights in latent variable modeling. Structural Equation Modeling 2005; 12: 411–434.
17.
Creswell KG, Chung T, Clark DB, Martin CS: Solitary cannabis use in adolescence as a correlate and predictor of cannabis problems. Drug Alcohol Depend 2015; 156: 120–125.
18.
Buckner JD, Ecker AH, Dean KE: Solitary cannabis use frequency mediates the relationship between social anxiety and cannabis use and related problems. Am J Addict 2016; 25: 99–104.
19.
van der Pol P, Liebregts N, Brunt T, van Amsterdam J, de Graaf R, Korf DJ, van den Brink W, van Laar M: Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addiction 2014; 109: 1101–1109.
20.
De Leeuw ED: Choosing the Method of Data Collection; in De Leeuw ED, Hox JJ, Dillman DA (eds): International Handbook of Survey Methodology. New York, Lawrence Earlbaum Associates, 2008, pp 117–135.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.